STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better

At the 2026 BIO conference in San Diego, biotech and startup executives discussed challenges posed by China's growing influence in drug development, strategies to strengthen the U.S. biotech industry, and the role of artificial intelligence in gaining competitive advantages. Key topics included navigating Washington politics, addressing pricing policies, and accelerating AI adoption.